[ad_1] <br><a href="https://news.google.com/atom/articles/CBMipgFodHRwczovL3d3dy5tYXJrZXRzY3JlZW5lci5jb20vcXVvdGUvc3RvY2svU0FOT0ZJLTQ2OTgvbmV3cy9QcmVzcy1SZWxlYXNlLUR1cGl4ZW50LWR1cGlsdW1hYi1hcHByb3ZlZC1ieS1FdXJvcGVhbi1Db21taXNzaW9uLWFzLWZpcnN0LWFuZC1vbmx5LXRhcmdldGVkLW1lZGktNDMyOTY0Njgv0gGqAWh0dHBzOi8vd3d3Lm1hcmtldHNjcmVlbmVyLmNvbS9hbXAvcXVvdGUvc3RvY2svU0FOT0ZJLTQ2OTgvbmV3cy9QcmVzcy1SZWxlYXNlLUR1cGl4ZW50LWR1cGlsdW1hYi1hcHByb3ZlZC1ieS1FdXJvcGVhbi1Db21taXNzaW9uLWFzLWZpcnN0LWFuZC1vbmx5LXRhcmdldGVkLW1lZGktNDMyOTY0Njgv?oc=5" target="_blank" rel="noopener">Press Release : Dupixent® (dupilumab) approved by European Commission as first and only targeted medicine for children as young as six months old with severe atopic dermatitis</a> <font color="#6f6f6f">Marketscreener.com</font> <br>[ad_2] <br><a href="https://news.google.com/atom/articles/CBMipgFodHRwczovL3d3dy5tYXJrZXRzY3JlZW5lci5jb20vcXVvdGUvc3RvY2svU0FOT0ZJLTQ2OTgvbmV3cy9QcmVzcy1SZWxlYXNlLUR1cGl4ZW50LWR1cGlsdW1hYi1hcHByb3ZlZC1ieS1FdXJvcGVhbi1Db21taXNzaW9uLWFzLWZpcnN0LWFuZC1vbmx5LXRhcmdldGVkLW1lZGktNDMyOTY0Njgv0gGqAWh0dHBzOi8vd3d3Lm1hcmtldHNjcmVlbmVyLmNvbS9hbXAvcXVvdGUvc3RvY2svU0FOT0ZJLTQ2OTgvbmV3cy9QcmVzcy1SZWxlYXNlLUR1cGl4ZW50LWR1cGlsdW1hYi1hcHByb3ZlZC1ieS1FdXJvcGVhbi1Db21taXNzaW9uLWFzLWZpcnN0LWFuZC1vbmx5LXRhcmdldGVkLW1lZGktNDMyOTY0Njgv?oc=5">Source link </a>
